ANIP icon

ANI Pharmaceuticals

146 hedge funds and large institutions have $337M invested in ANI Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

less funds holding

Funds holding:

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

88% less call options, than puts

Call options by funds: $1.72M | Put options by funds: $14M

Holders
146
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.72M
Puts
$14M
Net Calls
Net Calls Change

Top Buyers

1 +$6.18M
2 +$5.85M
3 +$5.06M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$4.85M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.49M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$66.9M
2
$24.9M
3
$22.3M
4
$19.8M
5
$19.6M
6
$15.2M
7
$14.3M
8
$12.6M
9
$8.23M
10
$8.14M
11
$7.82M
12
$7.51M
13
$6.4M
14
$5.96M
15
$5.4M
16
$4.88M
17
$3.55M
18
$3.49M
19
$3.22M
20
$3.14M
21
$2.88M
22
$2.82M
23
$2.75M
24
$2.58M
25
$2.45M